Marksans Pharma has shown strong growth and financial performance in recent times. However, there are concerns surrounding impairments, audit of subsidiaries, bad debts, disclosures, etc.
What is covered in the Full Insight:
Company Overview and Performance
Financial Performance Analysis
Geographic Breakdown of Operations
Goodwill and Impairment Analysis
Trade Discounts and Bad Debts
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.